Biology, Volume 15, Issue 3
2026 February-1 - 88 articles
Cover Story: In the post-smallpox era, Orthopoxvirus infections like Mpox pose a persistent and evolving public health threat. Monkeypox virus (MPXV), the cause of Mpox, was historically linked to sporadic zoonotic transmission but now increasingly spreads from human to human. While childhood smallpox vaccination is known to offer cross-protection against MPXV, the longevity of this immunity over a lifetime is unclear. We studied adults aged 79-94 who received vaccinia vaccination in childhood, evaluating their MPXV-specific antibody and T-cell responses after seven decades. All vaccinated participants showed strong binding and neutralizing antibodies, along with detectable cellular immunity, while those who were unvaccinated demonstrated no responses. Our findings indicate vaccinia-induced immunity can last over 70 years, protecting older adults from Mpox. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.